This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of the Global Anti-Hypertensive Drugs Market over the forecast period.
The global antihypertensive drugs market size is anticipated to reach USD 41,123.2 million by 2023, as per the findings of Market Research Future (MRFR). Antihypertensive drugs are indicated by reputed clinicians for the management of hypertension or elevated blood pressure. Long-term high blood pressure is one of the leading causes of heart failure, stroke, peripheral vascular disease, chronic kidney disease, and others. High prevalence of hypertension is the primary driver of the antihypertensive drugs market.
Get Free Sample Report @ https://www.marketresearchfuture.com/sample_request/2347
Awareness campaigns by non-profit and governmental organizations is likely to work in favor of the market. For instance, the Pulmonary Hypertension Association (PHA) offers education programs and has a strong support network which offers patients with right treatment information. Rising prevalence of chronic diseases is fueling the demand for antihypertensive drugs. In addition, the entry of generics which has brought down patient costs is projected to bode well for the market over the forecast period (2018-2023). The market can experience 2.67% CAGR over the forecast period owing to new forms of antihypertensive therapy options.
Report Overview
The report analyzes factors affecting the global antihypertensive drugs market by taking a microscopic view of various trends. It predicts the market size and volume based on first-class research undertaken by subject matter experts or research analysts at MRFR. The scope of the report covers drivers, restraints, opportunities, and threats engulfing the market. With easy-to-understand segmentation of the market by therapeutic class, type, distribution channel, and region, the market forecasts predictions based on historical and upcoming trends. Key players operating in the market are profiled coupled with their respective strategies for sustaining the market competition.
Competitive Analysis
Prominent players to get profiled in the antihypertensive drugs market report are United Therapeutics Corporation (U.S.), AstraZeneca (U.K.), Novartis AG (Switzerland), Pfizer, Inc. (U.S.), Daiichi Sankyo Company, Ltd. (Japan), Boehringer Engelheim GmbH (Germany), Johnson & Johnson Services, Inc. (U.S.), Takeda Pharmaceutical Company (Japan), Sanofi S.A. (France), Merck KGaA (Germany), and Bayer AG (Germany).
Segmentation
Various therapeutic classes of antihypertensive drugs discussed are calcium channel blockers, beta-adrenergic blockers, renin inhibitors, angiotensin-converting enzyme (ACE) inhibitors, vasodilators, diuretics, angiotensin II receptor blockers (ARBs), and others. By type, the antihypertensive drugs market is segmented into primary and secondary hypertension. Distribution channels covered in the market report include e-commerce websites and online drug stores, hospital pharmacy, retail pharmacy, and others.
Regional Analysis
The antihypertensive drugs market covers growth drivers in the following regions, namely Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA). The Americas accounted for a large market share owing to high prevalence of hypertension linked to cardiovascular and renal disorders. Drives by government and non-government organizations for creating awareness of the medical condition are likely to bolster the revenue of the antihypertensive drugs market in Americas.
The Europe region was the second-largest due to rise of cardiovascular diseases, unhealthy diets, and increase noticed in obesity levels of patients. According to the European Heart Network in 2017, heart diseases accounted for 3.9 million deaths. Germany, France, and the U.K. are expected to be the prime contributors to the antihypertensive drugs market in Europe.
The APAC region is projected to exhibit a robust pace owing to increased healthcare budget and rise in disposable income levels of patients. The setup of research and development centers to fast-track the commoditization of drugs for treating hypertension is likely to boost the APAC antihypertensive drugs market.
Browse Complete 85 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/anti-hypertensive-drugs-market-2347
1 Introduction
1.1 Definition
1.2 Scope Of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
3.5 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porter’s Five Forces Model
4.1.1 Bargaining Power Of Suppliers
4.1.2 Bargaining Power Of Customer
4.1.3 Intensity Of Competitor’s
4.1.4 Threat Of New Entrants
…Continued!
Send an Enquiry @ https://www.marketresearchfuture.com/enquiry/2347
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Your information will never be shared with any third party.